References
Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G (2012) Recombinant tissue plasminogen activator for acute ischemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–2372
The third international stroke trial (2012) (IST-3) collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischemic stroke (IST-3): a randomized controlled trial. Lancet 379:2352–2363
Ricci S, Cenciarelli S, Mazzoli T (2013) Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane Review: pros. Intern Emerg Med 8:653–654
Costantino G, Podda GM, Bonzi M, Sbrojavacca R (2013) Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane Review: cons. Intern Emerg Med 8:651–652
Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paciaroni, M. Italian guidelines on thrombolysis indications in ischemic stroke have been revised after the IST-3 trial and Cochrane review. Intern Emerg Med 9, 823–824 (2014). https://doi.org/10.1007/s11739-014-1109-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-014-1109-0